Johnson & Johnson cripples, God compensates
New Delhi: While Johnson & Johnson’s faulty hip implant was conspiring to cripple 44 year old Jyoti Rani Kona, God in heavens was making her marriage to compensate. Her Husband…
Drug companies turn to China, Japan after pricing pressure in west
HYDERABAD: Increasing price pressures in the North American market, which accounts for nearly a third of India’s pharmaceutical exports, is prompting domestic drug makers to explore avenues in new markets…
Sterling Biotech receives NBWs in Rs 8,100-crore bank loan fraud case
A Delhi court Saturday issued open-ended non-bailable warrants (NBWs) against four directors of a Gujarat pharma firm in a Rs 8,100-crore money laundering probe case. Additional Sessions Judge Satish Kumar…
Health ministry mulled compulsory licencing of rare disease drugs
NEW DELHI: The health ministry was actively mulling compulsory licensing, apart from price capping, of “orphan drugs” (for rare diseases), when the department of pharmaceuticals abruptly issued an order exempting…
Bristol-Myers Squibb buying Celgene in USD 74 bn deal
Bristol-Myers Squibb is buying Celgene in a cash-and-stock deal valued at about USD 74 billion. Shareholders of Celgene Corp, based in Summit, New Jersey, will receive one share of the…
Endeavour of govt is to provide affordable quality healthcare for all: Gowda
New Delhi: The government Thursday said it endeavours to provide affordable quality healthcare for all while also working to boost the domestic pharmaceutical sector through ‘Make in India’. As part…
Alembic Pharma gets USFDA nod for Parkinson’s treatment drug
New Delhi: Drug firm Alembic Pharmaceuticals Thursday said it has received approval from the US health regulator for Pramipexole Dihydrochloride extended-release tablets used for the treatment of Parkinson’s disease. The…
Biopharma Co Vyome gets Rs 154 crore from investors
New Delhi: Vyome Therapeutics, a biopharmaceutical firm focused on developing dermatology products, has raised $22 million (about Rs 154 crore) in a fresh round of funding led by Mumbai based…
Sun Pharma acquires Japan’s Pola Pharma
New Delhi: Drug major Sun Pharma Thursday said it has completed acquisition of Japan-based Pola Pharma to strengthen its presence in dermatology segment across the globe. The acquisition of 100…
Hetero Labs Limited acquires Tarbis Farma in Spain
Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, announced today that its European subsidiary Amarox Limited has acquired Tarbis Farma, S.L.U., a…
